EBITDA (2022)
77,2 (18,7% of turnover)
Our financial data in facts & figures
EBIT (2022)
51,7 (12,5% of turnover)
NET RESULT (2022)
37,8 (9,2% of turnover)
Related papers
OUR FIGURES BY FOCUS AREA (€ Millions, 2022)
Net revenue
412,1
€ Millions
OUR FIGURES BY PRODUCT CATEGORY (€ Millions, 2022)
PRESCRIPTION DRUGS: 42%*
MEDICAL DEVICES: 39%*
VACCINES: 5%*
OTHER: 14%*
*percentage referring to Fidia Farmaceutici S.p.A.
OUR FIGURES BY GEOGRAPHICAL AREA (€ Millions, 2022)
Net revenue
412,1
€ Millions
OUR GROUP
You are about to leave Fidia Pharma Middle East F.Z.E. website.
All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.
PROCEED
